Trial Details
WITHDRAWNBasic Information
| Clinical ID | c2300 |
|---|---|
| Identifier | NCT03712826 |
| Trial Title | Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Anti-TNF Drug|DRUG: Ustekinumab |
Participant Information
| Sponsor | Hospices Civils de Lyon |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2022-07-24 |
|---|---|
| Primary Completion Date | 2022-07-24 |
| Completion Date | 2022-07-24 |